| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |